Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $204.85 | Total: $1,024.25 |
| 1 | 10 | $173.52 | Total: $1,735.20 |
| 1 | 25 | $147.01 | Total: $3,675.25 |
| 1 | 50 | $125.32 | Total: $6,266.00 |
| 1 | 100 | $108.45 | Total: $10,845.00 |
Overview
Zunsemetinib (ATI-450) is an orally active and selective inhibitor of the p38? mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway.Zunsemetinib is used to study spondyloarthritis and rheumatoid arthritis.
Chemical Properties
| Molecular Formula | C25H22ClF2N5O3 |
| Molecular Weight | 513.92 |
| CAS Numbers | 1640282-42-3 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | Cc1cnc(cc1-n1c(C)cc(OCc2ncc(F)cc2F)c(Cl)c1=O)-c1ccnc(n1)C(C)(C)O |
Storage and Handling
0C Short Term, -20C Long Term
References
Zunsemetinib [ATI-450]